Clinical trial
Head and Intraocular Trauma Tool (HITT) for the Identification of Mild Traumatic Brain Injury
NCT05092282 is registered in ClinicalTrials.gov with Rebiscan, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Head and Intraocular Trauma Tool (HITT) for the Identification of Mild Traumatic Brain Injury
- Lead sponsor
- Rebiscan, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2021
- Completion date
- December 31, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.